Review Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: In combination with chemotherapy, with the therapy of adult patients with domestically recurrent unresectable or metastatic triple-negative breast most cancers who have not acquired prior chemotherapy for metastatic disorder and whose tumours Convey programmed cell Loss of life-ligand one (combined positi... https://charlesi019fiq2.bloggip.com/profile